Safety data from 48 weeks follow-up of a randomised controlled trial of rituximab in patients with rheumatoid arthritis.

被引：0
|
作者：
Szczepanski, L
Szechinski, J
Filipowicz-Sosnowska, A
Emery, P
Edwards, JCW
Magrini, F
Lehane, PB
Shaw, TM
机构：
[1] Med Univ Lublin, Lublin, Poland
[2] Univ Wroclaw, Sch Med, PL-50138 Wroclaw, Poland
[3] Inst Rheumatol, Warsaw, Poland
[4] Leeds Gen Infirm, Leeds, W Yorkshire, England
[5] UCL, London, England
[6] Roche Prod Ltd, Welwyn Garden City, Herts, England
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
204
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [1] SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. ELEVEN-YEAR FOLLOW-UP OBSERVATIONAL STUDY
    Rodriguez Garcia, S. D. L. C.
    Castellanos-Moreira, R.
    Hernandez-Miguel, M. V.
    Cuervo, A.
    Camacho, O.
    Ruiz-Esquide, V.
    Ramirez, J.
    Canete, J. D.
    Gomez Puerta, J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1394 - 1395
  • [2] Rituximab Safety in Patients with Rheumatoid Arthritis. an Eleven-Year Follow-up Observational Study
    Castellanos-Moreira, Raul, Sr.
    Rodriguez-Garcia, Sebastian C.
    Victoria Hernandez, M.
    Ruiz-Esquide, Virginia
    Camacho, Oscar, Sr.
    Cuervo, Andrea
    Ramirez, Julio
    Canete, Juan
    Gomez Puerta, Jose
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial
    Williamson, Esther
    McConkey, Christopher
    Heine, Peter
    Dosanjh, Sukhdeep
    Williams, Mark
    Lamb, Sarah E.
    BMJ OPEN, 2017, 7 (04):
  • [4] Long-term safety data from extended follow-up and repeat use of rituximab in rheumatoid arthritis
    van Vollenhoven, R.
    Emery, R.
    Bingham, C.
    Keystone, E.
    Greenwald, M.
    Moreland, L. W.
    Sweetser, M.
    Rowe, K.
    Wagner, B.
    Magrini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 89
  • [5] Safety of Rituximab in Patients with Chronic Inflammatory Arthritis. Seven-Year Follow-up Observational Study
    Cuervo, Andrea
    Victoria Hernandez, M.
    Cabrera, Sonia
    Inciarte-Mundo, Jose
    Ramirez, Julio
    Ruiz-Esquide, Virginia
    Canete, Juan D.
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S201 - S202
  • [6] Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis
    Emery, Paul
    van Vollenhoven, Ronald F.
    Binghamlll, Clifton O.
    Keystone, Edward C.
    Greenwald, Maria
    Moreland, Larry W.
    Sweetser, Marianne
    Rowe, Karen
    Wagner, Bridget
    Magrini, Fabio
    RHEUMATOLOGY, 2008, 47 : II16 - II16
  • [7] Duration of response to a single treatment course of rituximab (RTX) in active rheumatoid arthritis (RA): Efficacy and safety data from a 2-year follow-up of a randomised trial
    Sheeran, T
    Emery, P
    Lehane, PB
    Saiedabadi, N
    Shaw, TM
    RHEUMATOLOGY, 2005, 44 : I2 - I2
  • [8] Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis
    van Vollenhoven, Ronald
    Haraoui, Boulos
    Emery, Paul
    Bingham, Clifton
    Keystone, Edward
    Greenwald, Maria
    Moreland, Larry
    Sweetser, Marianne
    Rowe, Karen
    Wagner, Bridget
    Magrini, Fabio
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1187 - 1188
  • [9] Long-term safety data from extended follow-up and repeat use of Rituximab (RTX) in patients with active rheumatoid arthritis (RA)
    Ronald, Van Vollenhoven
    Tore, Kvien
    Jean, Sibilia
    Paul, Emery
    Clifton, Bingham
    Edward, Keystone
    Maria, Greenwald
    Larry, Moreland
    Marrianne, Sweetser
    Karen, Rowe
    Bridget, Wagner
    Fabio, Magrini
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 51 - 51
  • [10] OUTPATIENT FOLLOW UP ON DEMAND FOR PATIENTS WITH RHEUMATOID ARTHRITIS - A TWO-YEAR RANDOMISED CONTROLLED TRIAL
    Sweeney, A. -M. T.
    Madsen, O. R.
    Dreyer, L.
    Hansen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 152 - 152
12345